SAMSRITA LABS LIMITED (SAMSRITA.BO)
INR 14.84
(0.0%)
INR 14.84
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 21.98 Million INR | 6.22% |
| 2022 | 20.7 Million INR | -24.21% |
| 2021 | 27.31 Million INR | 16.91% |
| 2020 | 23.36 Million INR | -72.69% |
| 2019 | 85.54 Million INR | 8.35% |
| 2018 | 78.95 Million INR | 22.21% |
| 2017 | 64.6 Million INR | -0.24% |
| 2016 | 64.75 Million INR | 7996.83% |
| 2015 | -820.03 Thousand INR | 16.75% |
| 2014 | -985 Thousand INR | -1084.67% |
| 2013 | -83.14 Thousand INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | 30 Thousand INR | -99.86% |
| 2023 Q1 | 53 Thousand INR | -99.74% |
| 2023 Q4 | 21.98 Million INR | 73195.16% |
| 2023 FY | 21.98 Million INR | 6.22% |
| 2023 Q2 | 21.65 Million INR | 40758.49% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 28.87 Million INR | 0.0% |
| 2022 Q4 | 20.7 Million INR | 0.0% |
| 2022 FY | 20.7 Million INR | -24.21% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 27.31 Million INR | 16.91% |
| 2021 Q4 | 27.31 Million INR | 15331.52% |
| 2021 Q3 | 177 Thousand INR | -99.82% |
| 2021 Q2 | 95.99 Million INR | 72620.45% |
| 2021 Q1 | 132 Thousand INR | -99.86% |
| 2020 FY | 23.36 Million INR | -72.69% |
| 2020 Q3 | 141 Thousand INR | -99.84% |
| 2020 Q2 | 89.43 Million INR | 3207.32% |
| 2020 Q1 | 2.7 Million INR | -96.84% |
| 2020 Q4 | 93.81 Million INR | 66434.83% |
| 2019 Q2 | 79.67 Million INR | 34543.04% |
| 2019 Q3 | 311 Thousand INR | -99.61% |
| 2019 FY | 85.54 Million INR | 8.35% |
| 2019 Q1 | 230 Thousand INR | 0.0% |
| 2019 Q4 | 85.54 Million INR | 27406.53% |
| 2018 FY | 78.95 Million INR | 22.21% |
| 2017 FY | 64.6 Million INR | -0.24% |
| 2016 Q2 | -497 Thousand INR | 0.0% |
| 2016 Q3 | 497 Thousand INR | 200.0% |
| 2016 Q4 | 64.75 Million INR | 12929.57% |
| 2016 FY | 64.75 Million INR | 7996.83% |
| 2015 FY | -820.03 Thousand INR | 16.75% |
| 2014 FY | -985 Thousand INR | -1084.67% |
| 2014 Q1 | 83 Thousand INR | 0.0% |
| 2014 Q4 | -985 Thousand INR | 0.0% |
| 2013 FY | -83.14 Thousand INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 98.377% |
| Biocon Limited | 140.18 Billion INR | 99.984% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 102.646% |
| Concord Biotech Limited | -372.86 Million INR | 105.897% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 99.884% |
| FERMENTA BIOTECH LIMITED | 1.1 Billion INR | 98.009% |
| GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | 36305.881% |
| Lyka Labs Limited | 527.01 Million INR | 95.828% |
| Panacea Biotec Limited | -1.18 Billion INR | 101.856% |
| Servoteach Industries Limited | 5016.00 INR | -438282.775% |
| SMS Lifesciences India Limited | 992.31 Million INR | 97.784% |
| Supriya Lifescience Limited | -694.68 Million INR | 103.165% |
| Syngene International Limited | -83 Million INR | 126.493% |
| TAKE Solutions Limited | 361.37 Million INR | 93.915% |
| Titan Biotech Limited | 54.62 Million INR | 59.747% |
| Transgene Biotek Limited | 139.93 Million INR | 84.286% |
| Vanta Bioscience Limited | 607.93 Million INR | 96.383% |